What it will take to end malaria — and why Britain’s leadership still matters

The COVID-19 pandemic exposed how vulnerable the world remains to infectious diseases. Faster, more efficient clinical development pathways accelerate access to vaccines and therapeutics. Infectious diseases continue to disproportionately affect low- and middle-income countries, where healthcare, diagnostics and treatment access are often limited, and healthcare systems are more vulnerable to disruption. Product development challenges Despite … Continued